Literature DB >> 3995281

Catecholamine topochemistry in human basal ganglia. Comparison between normal and Alzheimer brains.

P Nyberg, R Adolfsson, J A Hardy, A Nordberg, P Wester, B Winblad.   

Abstract

Analysis of catecholamine levels in postmortem human control and Alzheimer brains revealed lower mean concentrations of noradrenaline, but not dopamine, in nucleus caudatus, putamen and globus pallidus, but not in hippocampus, of the Alzheimer brains. Generally, noradrenaline levels were higher in the more posterior parts of nucleus caudatus and putamen in the control brains, whereas such gradients were absent in the Alzheimer brains.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3995281     DOI: 10.1016/0006-8993(85)90133-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  The basis for behavioural disturbances in dementia.

Authors:  K A Jellinger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

2.  Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile.

Authors:  A Nordberg; P Nyberg; R Adolfsson; B Winblad
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

3.  Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease.

Authors:  Adele Romano; Lorenzo Pace; Bianca Tempesta; Angelo Michele Lavecchia; Teresa Macheda; Gaurav Bedse; Antonio Petrella; Carlo Cifani; Gaetano Serviddio; Gianluigi Vendemiale; Silvana Gaetani; Tommaso Cassano
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

4.  Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.

Authors:  Agnieszka Ciesielska; Lluis Samaranch; Waldy San Sebastian; Dennis W Dickson; Samuel Goldman; John Forsayeth; Krystof S Bankiewicz
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.